Crossmark Global Holdings’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.56M Sell
51,594
-343
-0.7% -$23.7K 0.06% 304
2025
Q1
$3.61M Buy
51,937
+841
+2% +$58.4K 0.06% 291
2024
Q4
$4.4M Sell
51,096
-1,500
-3% -$129K 0.08% 251
2024
Q3
$6.26M Buy
52,596
+12,539
+31% +$1.49M 0.11% 216
2024
Q2
$5.72M Buy
40,057
+1,455
+4% +$208K 0.11% 215
2024
Q1
$4.96M Sell
38,602
-1,949
-5% -$250K 0.1% 234
2023
Q4
$4.2M Buy
40,551
+487
+1% +$50.4K 0.09% 247
2023
Q3
$3.73M Sell
40,064
-84
-0.2% -$7.81K 0.08% 253
2023
Q2
$3.17M Buy
40,148
+892
+2% +$70.4K 0.07% 308
2023
Q1
$3.12M Buy
39,256
+228
+0.6% +$18.1K 0.07% 297
2022
Q4
$2.64M Sell
39,028
-354
-0.9% -$24K 0.07% 323
2022
Q3
$1.96M Buy
39,382
+5,222
+15% +$260K 0.05% 364
2022
Q2
$1.9M Sell
34,160
-1,520
-4% -$84.7K 0.05% 393
2022
Q1
$1.98M Buy
35,680
+3,560
+11% +$198K 0.04% 421
2021
Q4
$1.8M Buy
32,120
+510
+2% +$28.6K 0.04% 448
2021
Q3
$1.52M Buy
31,610
+220
+0.7% +$10.6K 0.04% 478
2021
Q2
$1.32M Sell
31,390
-3,700
-11% -$155K 0.03% 523
2021
Q1
$1.18M Sell
35,090
-66,490
-65% -$2.24M 0.03% 541
2020
Q4
$3.55M Sell
101,580
-7,806
-7% -$273K 0.09% 247
2020
Q3
$3.8M Buy
109,386
+90
+0.1% +$3.12K 0.11% 207
2020
Q2
$3.58M Buy
109,296
+57,090
+109% +$1.87M 0.1% 217
2020
Q1
$1.57M Sell
52,206
-2,172
-4% -$65.4K 0.06% 338
2019
Q4
$1.57M Sell
54,378
-68,272
-56% -$1.98M 0.04% 438
2019
Q3
$3.17M Sell
122,650
-39,368
-24% -$1.02M 0.09% 245
2019
Q2
$4.14M Buy
162,018
+3,018
+2% +$77K 0.12% 210
2019
Q1
$4.16M Buy
159,000
+7,816
+5% +$204K 0.12% 209
2018
Q4
$3.48M Sell
151,184
-1,000
-0.7% -$23K 0.11% 227
2018
Q3
$3.59M Buy
152,184
+38,166
+33% +$900K 0.09% 262
2018
Q2
$2.63M Sell
114,018
-79,174
-41% -$1.83M 0.07% 311
2018
Q1
$4.76M Sell
193,192
-34,260
-15% -$844K 0.12% 204
2017
Q4
$6.1M Buy
227,452
+53,922
+31% +$1.45M 0.15% 175
2017
Q3
$4.18M Buy
+173,530
New +$4.18M 0.11% 229
2016
Q3
$4.18M Buy
+173,530
New +$4.18M 0.11% 229